Cytovance recently appeared on the Outsourced Pharma Large Molecule Capabilities Update to share how our available capacity, experince in microbial and mammalian expression systems, US-based manufacturing facilities, and high scale-up success rate are helping industry customers meet product milestones. View the video below to hear from Rose Rhomberg, our Senior Director of Business Development, on […]

Outsourced Pharma Capabilities Update – March 2026 Read More »

Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity,  current microbial and mammalian capabilities, US-based manufacturing, and high scale-up success rate are helping industry customers meet product milestones. View the video below to hear from Bill Wang, PhD, our Director of Business Development, on the agility and experience that make

Outsourced Pharma Capacity Update – October 2025 Read More »